Kinaxo, AstraZeneca Partner on Oncology Program

Kinaxo will use it mass spectrometry-based technologies to quantitatively analyze post-translational modifications in proteins on a proteome-wide scale.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.